Irving Kirsch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Irving Kirsch has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Giuliana Mazzoni
University of Hull, Department of Psychology, Cottingham Road, Hull HU5 3EY, United Kingdom
4 shared publicationsBlair T Johnson
2 shared publicationsGuy H. Montgomery
2 shared publicationsKathrine Roberts
University of Hull, Department of Psychology, Cottingham Road, Hull HU5 3EY, United Kingdom
2 shared publicationsAlan Scoboria
Department of Psychology, University of Windsor, Windsor, Ontario, Canada
1 shared publicationAmanda Cook
Northwestern University
1 shared publication
Latest Publications
- 1 January 2014
- Published by American Psychological Association (APA) in Psychology of Consciousness: Theory, Research, and Practice
- Vol. 1 (1) , 51-59
Expectancy and conditioning in placebo analgesia: Separate or connected processes?
Expectancy and conditioning are often tested as opposing explanations of placebo analgesia, most commonly by pitting the effects of a conditioning procedure against those of a verbally-induced expectation for pain reduction. However, conditioning procedures can also alter expectations, such that the effect of conditioning on pain might be mediated by expectancy. We assessed the effect of conditioning on expected pain and placebo-induced pain reduction. Participants were told that the treatment (real or sham acupuncture) would affect one side of the arm but not the other. Because a real acupuncture effect would not be specific to a randomly selected side of the arm, any difference in pain between the “treated” and the “untreated” side would be a placebo effect. There were no significant main effects or interactions associated with type of acupuncture (real versus sham). In both groups, conditioning decreased expected pain for “treated” location and also increased the placebo effect (i.e., the difference in pain report between “treated” and “untreated” locations). In addition, mediation analysis lent support to the hypothesis that the effects of conditioning on placebo analgesia may be mediated by expectancy, although the size of this indirect effect requires further study.
- 1 January 2014
- Published by American Psychological Association (APA) in Psychology of Consciousness: Theory, Research, and Practice
- Vol. 1 (1) , 51-59
Expectancy and conditioning in placebo analgesia: Separate or connected processes?
Expectancy and conditioning are often tested as opposing explanations of placebo analgesia, most commonly by pitting the effects of a conditioning procedure against those of a verbally-induced expectation for pain reduction. However, conditioning procedures can also alter expectations, such that the effect of conditioning on pain might be mediated by expectancy. We assessed the effect of conditioning on expected pain and placebo-induced pain reduction. Participants were told that the treatment (real or sham acupuncture) would affect one side of the arm but not the other. Because a real acupuncture effect would not be specific to a randomly selected side of the arm, any difference in pain between the “treated” and the “untreated” side would be a placebo effect. There were no significant main effects or interactions associated with type of acupuncture (real versus sham). In both groups, conditioning decreased expected pain for “treated” location and also increased the placebo effect (i.e., the difference in pain report between “treated” and “untreated” locations). In addition, mediation analysis lent support to the hypothesis that the effects of conditioning on placebo analgesia may be mediated by expectancy, although the size of this indirect effect requires further study.
- 1 April 2013
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 21 (2) , 102-104
The placebo effect revisited: Lessons learned to date
- 1 April 2013
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 21 (2) , 102-104
The placebo effect revisited: Lessons learned to date
- 4 January 2013
- Published by Taylor & Francis in American Journal of Clinical Hypnosis
- Vol. 55 (3) , 221-229
Suggestion in the Treatment of Depression
Meta-analyses consistently reveal that most of the response to antidepressant treatment can be obtained by placebo, and the difference between response to the drug and the response to any treatment is not clinically significant for most individuals diagnosed with major depressive disorder. Furthermore, the best predictor of antidepressant efficacy is the response to placebo during the so-called placebo run-in period. It can also be shown that a significant portion of the placebo effect is expectancy. These data thus indicate that suggestion is a central factor in treating depression. Therefore, the use of hypnosis, which is based on suggestion, as a treatment adjunct can be expected to enhance treatment outcome.
- 4 January 2013
- Published by Taylor & Francis in American Journal of Clinical Hypnosis
- Vol. 55 (3) , 221-229
Suggestion in the Treatment of Depression
Meta-analyses consistently reveal that most of the response to antidepressant treatment can be obtained by placebo, and the difference between response to the drug and the response to any treatment is not clinically significant for most individuals diagnosed with major depressive disorder. Furthermore, the best predictor of antidepressant efficacy is the response to placebo during the so-called placebo run-in period. It can also be shown that a significant portion of the placebo effect is expectancy. These data thus indicate that suggestion is a central factor in treating depression. Therefore, the use of hypnosis, which is based on suggestion, as a treatment adjunct can be expected to enhance treatment outcome.
- 30 June 2011
- Published by Elsevier in Consciousness and Cognition
- Vol. 20 (2) , 335-336
Suggestibility and suggestive modulation of the Stroop effect
- 30 June 2011
- Published by Elsevier in Consciousness and Cognition
- Vol. 20 (2) , 335-336
Suggestibility and suggestive modulation of the Stroop effect
- 27 June 2011
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 366 (1572) , 1781-1782
Preface
- 27 June 2011
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 366 (1572) , 1781-1782
Preface
- 1 June 2011
- Published by Taylor & Francis in International Journal of Clinical and Experimental Hypnosis
- Vol. 59 (3) , 350-362
The Altered State Issue:Dead or Alive?
Theoretical positions on the altered-state issue are viewed on a continuum rather than a dichotomy. While differences between some pairs of positions have little or no substantive interest, others are important to understanding the nature of hypnotic phenomena. Recent brain imaging data from the University of Hull are reviewed with respect to their implications concerning the existence and functional significance of the hypothesized hypnotic state.
- 1 June 2011
- Published by Taylor & Francis in International Journal of Clinical and Experimental Hypnosis
- Vol. 59 (3) , 350-362
The Altered State Issue:Dead or Alive?
Theoretical positions on the altered-state issue are viewed on a continuum rather than a dichotomy. While differences between some pairs of positions have little or no substantive interest, others are important to understanding the nature of hypnotic phenomena. Recent brain imaging data from the University of Hull are reviewed with respect to their implications concerning the existence and functional significance of the hypothesized hypnotic state.
- Open Access
- 1 April 2011
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 56 (4) , 191-192
The Use of Placebos in Clinical Trials and Clinical Practice
- 1 April 2011
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 56 (4) , 191-192
Open AccessThe Use of Placebos in Clinical Trials and Clinical Practice
- 1 December 2009
- Published by Cambridge University Press (CUP) in Epidemiology and Psychiatric Sciences
- Vol. 18 (4) , 318-322
Antidepressants and the placebo response
SUMMARY: Aims – To evaluate new generation antidepressants in relation to the placebo response. Methods – I review meta-analyses in which response to antidepressant medication and response to placebo were calculated. Results – All but one of these meta-analyses included unpublished as well as published trials. Most trials failed to show a significant advantage of SSRIs over inert placebo, and the differences between drug and placebo are not clinically significant for most depressed patients. Documents obtained from the U.S. Food and Drug Administration (FDA) revealed an explicit decision to keep this information from the public and from prescribing physicians. Conclusions – Because they do not incur drug risks, exercise and psychotherapy, which show at benefits at least equal to those of antidepressants, may be a better treatment choice for depressed individuals.Declaration of Interest: The author has not in the last 2 years received any support, including that from drug companies and honoraria for lectures and consultancies, from interests potentially in conflict with this work.
- 1 December 2009
- Published by Cambridge University Press (CUP) in Epidemiology and Psychiatric Sciences
- Vol. 18 (4) , 318-322
Antidepressants and the placebo response
SUMMARY: Aims – To evaluate new generation antidepressants in relation to the placebo response. Methods – I review meta-analyses in which response to antidepressant medication and response to placebo were calculated. Results – All but one of these meta-analyses included unpublished as well as published trials. Most trials failed to show a significant advantage of SSRIs over inert placebo, and the differences between drug and placebo are not clinically significant for most depressed patients. Documents obtained from the U.S. Food and Drug Administration (FDA) revealed an explicit decision to keep this information from the public and from prescribing physicians. Conclusions – Because they do not incur drug risks, exercise and psychotherapy, which show at benefits at least equal to those of antidepressants, may be a better treatment choice for depressed individuals.Declaration of Interest: The author has not in the last 2 years received any support, including that from drug companies and honoraria for lectures and consultancies, from interests potentially in conflict with this work.
- 30 June 2009
- Published by Elsevier in Consciousness and Cognition
- Vol. 18 (2) , 494-499
Suggested visual hallucinations in and out of hypnosis
- 30 June 2009
- Published by Elsevier in Consciousness and Cognition
- Vol. 18 (2) , 494-499
Suggested visual hallucinations in and out of hypnosis
- Open Access
- 1 December 2008
- Published by McGill University Library and Archives in McGill Journal of Medicine
- Vol. 11 (2) , 219-22
Challenging Received Wisdom: Antidepressants and the Placebo Effect
This article explores the reaction when an article challenging received wisdom is published and covered extensively by the media (1). The article in question was a meta-analysis of antidepressant clinical trials indicating that for most patients, difference between drug and placebo was not clinically significant. Reactions ranged from denial that the effects of antidepressants are so small to criticisms of the clinical trials that were analyzed. Each of these reactions is explored and countered.
- 1 December 2008
- Published by McGill University Library and Archives in McGill Journal of Medicine
- Vol. 11 (2) , 219-22
Open AccessChallenging Received Wisdom: Antidepressants and the Placebo Effect
This article explores the reaction when an article challenging received wisdom is published and covered extensively by the media (1). The article in question was a meta-analysis of antidepressant clinical trials indicating that for most patients, difference between drug and placebo was not clinically significant. Reactions ranged from denial that the effects of antidepressants are so small to criticisms of the clinical trials that were analyzed. Each of these reactions is explored and countered.